Mode
Text Size
Log in / Sign up
Phase 3 Completed N=85 Randomized Single-blind Treatment

An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome

Source: ClinicalTrials.gov NCT00131573 ↗
Enrolled (actual)
85
Serious AEs
0.0%
Results posted
Nov 2013
Primary outcomePrimary: Average Number of Voids Per Day — NA; NA Average Number of Voids

Summary

The goal of this study is to investigate the safety and effectiveness of a new implanted device designed to treat Urinary Urgency-Frequency Syndrome.

Outcome Measures

OutcomeResultp-value
PRIMARY
Average Number of Voids Per Day
NA; NA
PRIMARY
Freedom From Major Complications
0; 0

Eligibility Criteria

Key Inclusion criteria

  • Age 18 years and above.
  • Diagnosed with urinary urgency-frequency syndrome.
  • Have no reported history of urethral obstruction/stricture, bladder calculi or bladder tumor.
  • Have normal upper urinary tract function.
  • Be capable of giving informed consent.
  • Be capable and willing to follow all study related procedures.

Key Exclusion Criteria

  • Have any active implantable device regardless of whether stimulation status is ON or OFF.
  • Are pregnant as confirmed by a urine pregnancy test or plan to become pregnant during the following 12 month period.
  • Less than one year post partum and/or are breast-feeding.
  • Have any large passive implant that contains metal located within 30 cm of the chair pad while seated (e.g., hip replacement).
  • Have conditions requiring magnetic resonance imaging (MRI) evaluation.
  • Have conditions requiring diathermy procedures.
  • Have an inability to operate the bion Remote Control and bion Recharging System either by self or caregiver.
  • Have diabetes with peripheral nerve involvement or have severe uncontrolled diabetes.
  • Have history of coagulopathy or bleeding disorder.
  • Have pelvic pain in the absence of voiding dysfunction.
  • Have anatomical restrictions such that the study device placement is not possible.
  • Are currently participating or have participated within the past 30 days in any clinical investigation involving or impacting urinary or renal function.
  • Cannot independently comprehend and complete the questionnaires.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00131573). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search